InMed Pharmaceuticals Inc. (30) | Business Finance (16)

Browse by Subcategory

Recent Contracts

Form of Securities Purchase Agreement (Filed With SEC on February 5, 2021)
Form of Common Share Purchase Warrant (Filed With SEC on February 5, 2021)
Form of Registration Rights Agreement (Filed With SEC on February 5, 2021)
Underwriting Agreement, dated November 12, 2020, by and between InMed Pharmaceuticals Inc. and Roth Capital Partners, LLC, as representative of the underwriters named therein (Filed With SEC on November 12, 2020)
InMed Pharmaceuticals Inc. 2017 Stock Option Plan (Filed With SEC on June 19, 2020)
Share Purchase Agreement, dated May 10, 2014, among Meridex Software Corporation, Biogen Sciences Inc. and the Shareholders of Biogen Sciences Inc (Filed With SEC on June 19, 2020)
Assignment of Intellectual Property, dated as of October 28, 2015, between Dr. Sazzad Hossain and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)
Form of Public Warrant (Filed With SEC on November 12, 2020)
Form of Public Warrant (Filed With SEC on October 8, 2020)
Form of Pre-Funded Warrant (Filed With SEC on October 8, 2020)
Form of Underwriting Agreement (Filed With SEC on September 15, 2020)
Form of Underwriting Agreement (Filed With SEC on July 6, 2020)
Form of Stock Option Agreement pursuant to the InMed Pharmaceuticals Inc. 2017 Stock Option Plan (Filed With SEC on June 19, 2020)
Section 85 Purchase and Sale Agreement, dated as of October 28, 2015, between Dr. Sazzad Hossain and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)
Technology Assignment Agreement, dated as of May 31, 2017, between The University of British Columbia and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)
Amendment No. 1 to Technology Assignment Agreement, dated as of May 31, 2017, between The University of British Columbia and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)